Eli Lilly

How Lilly Oncology is aiming to improve clinical trial diversity

Insmed

An inside look at Insmed

Amylyx

Amylyx Pharmaceuticals preps NDA filing for ALS drug AMX0035  

Urovant

A closer look at Urovant’s vibegron blood pressure study

Hookipa

Hookipa Pharma announces oncology partnership with Merck

Theravance Biopharma

Theravance cuts 75% of staff after ampreloxetine failure

Urovant

Urovant shares positive data at the annual meeting of the American Urological Association

covid-19 vaccine

COVID-19 vaccine booster tensions mount between White House, CDC and FDA

QurAlis

QurAlis selects development candidate for ALS